Journal Article
. 2013 Jan; 18(3):270-9.
doi: 10.1177/1074248412472257.

Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats

Wangde Dai 1 Paul Gerczuk  Yuanyuan Zhang  Leona Smith  Oleg Kopyov  Gregory L Kay  Aarne J Jyrala  Robert A Kloner  
  • PMID: 23345062
  •     12 citations


Aims: We determined whether implantation of heart tissue-derived decellularized matrix, which contains native biochemical and structural matrix composition, could thicken the infarcted left ventricular (LV) wall and improve LV function in a rat myocardial infarction model.

Methods And Results: Myocardial infarction was induced by left coronary ligation in Fischer rats. One week later, saline (75 μL, n = 17) or matrix (75 μL, n = 19) was directly injected into the infarcted area. At 6 weeks after injection, cardiac function was assessed by left ventriculogram, echocardiography, and Millar catheter. The hearts were pressure fixed to measure postmortem LV volume and processed for histology. Left ventriculogram demonstrated that LV ejection fraction (EF) was significantly greater in the matrix-treated (56.7% ± 1.4%) than in the saline-treated group (52.4% ± 1.5%; P = .043), and paradoxical LV systolic bulging was significantly reduced in the matrix-treated group (6.2% ± 1.6% of the LV circumference) compared to the saline-treated group (10.3% ± 1.3%; P = .048). Matrix implantation significantly increased the thickness of infarcted LV wall (0.602 ± 0.029 mm) compared to the saline-treated group (0.484 ± 0.03 mm; P = .0084). Infarct expansion index was significantly lower in the matrix-treated group (1.053 ± 0.051) than in the saline-treated group (1.382 ± 0.096, P = .0058). Blood vessel density and c-kit positive staining cells within the infarct area were comparable between the 2 groups.

Conclusions: Implantation of heart tissue-derived decellularized matrix thickens the LV infarcted wall, prevents paradoxical LV systolic bulging, and improves LV EF after myocardial infarction in rats. This benefit was not dependent on the enhanced angiogenesis or the recruitment of endogenous stem cells to the injury site.

Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
Andriy Yabluchanskiy, Yonggang Ma, +2 authors, Merry L Lindsey.
Physiology (Bethesda), 2013 Nov 05; 28(6). PMID: 24186934    Free PMC article.
Highly Cited. Review.
Delivering stem cells to the healthy heart on biological sutures: effects on regional mechanical function.
Ze-Wei Tao, John T Favreau, +5 authors, Glenn R Gaudette.
J Tissue Eng Regen Med, 2014 Apr 23; 11(1). PMID: 24753390    Free PMC article.
In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'.
Isaac Perea-Gil, Cristina Prat-Vidal, Antoni Bayes-Genis.
Stem Cell Res Ther, 2015 Dec 17; 6. PMID: 26670389    Free PMC article.
Striated muscle function, regeneration, and repair.
I Y Shadrin, A Khodabukus, N Bursac.
Cell Mol Life Sci, 2016 Jun 09; 73(22). PMID: 27271751    Free PMC article.
The cytoprotective capacity of processed human cardiac extracellular matrix.
Benjamin Kappler, Petra Anic, +7 authors, Christof Stamm.
J Mater Sci Mater Med, 2016 Jun 09; 27(7). PMID: 27272902
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats.
Domenico G Della Rocca, Bradley J Willenberg, +13 authors, Carl J Pepine.
Int J Cardiol, 2016 Jul 06; 220. PMID: 27379917    Free PMC article.
Plant-based foods containing cell wall polysaccharides rich in specific active monosaccharides protect against myocardial injury in rat myocardial infarction models.
Sun Ha Lim, Yaesil Kim, +4 authors, Jongwon Lee.
Sci Rep, 2016 Dec 09; 6. PMID: 27929093    Free PMC article.
Artificial Cardiac Muscle with or without the Use of Scaffolds.
Yifei Li, Donghui Zhang.
Biomed Res Int, 2017 Sep 07; 2017. PMID: 28875152    Free PMC article.
A Cell-Enriched Engineered Myocardial Graft Limits Infarct Size and Improves Cardiac Function: Pre-Clinical Study in the Porcine Myocardial Infarction Model.
Isaac Perea-Gil, Cristina Prat-Vidal, +8 authors, Antoni Bayes-Genis.
JACC Basic Transl Sci, 2016 Aug 29; 1(5). PMID: 30167524    Free PMC article.
Extracellular matrix from decellularized mesenchymal stem cells improves cardiac gene expressions and oxidative resistance in cardiac C-kit cells.
Wai Hoe Ng, Rajesh Ramasamy, +4 authors, Jun Jie Tan.
Regen Ther, 2019 Jun 14; 11. PMID: 31193142    Free PMC article.
Cardiac Extracellular Matrix Modification as a Therapeutic Approach.
Mikayla L Hall, Brenda M Ogle.
Adv Exp Med Biol, 2018 Sep 22; 1098. PMID: 30238369    Free PMC article.
3-D Human Renal Tubular Organoids Generated from Urine-Derived Stem Cells for Nephrotoxicity Screening.
Haibin Guo, Nan Deng, +5 authors, Yuanyuan Zhang.
ACS Biomater Sci Eng, 2020 Dec 16; 6(12). PMID: 33320634    Free PMC article.